Artivion | CRY - Pre Tax Profit


Artivion reported $11.4M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD 362M 368M Jun/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Boston Scientific USD 1.42B 261M Jun/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
Inogen USD -6.06M 467K Sep/2024
Integra LifeSciences USD -2.41M 6.72M Mar/2026
J&J USD 8.66B 839M Jun/2026
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Orthofix International USD -2.19M 20.07M Dec/2025
Pfizer USD -653M 5.84B Jun/2026
ResMed USD 502.31M 6.16M Mar/2026
Stryker USD 850M 855M Mar/2026
Tandem Diabetes Care USD -19.88M 24.56M Mar/2026
Teleflex USD -3.83M 222.77M Mar/2026
Terumo JPY 90.32B 58.66B Jun/2026
Trinity Biotech USD -5.06M 10.74M Sep/2025